KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biocryst Pharmaceuticals (BCRX) Short-term Investments: 2010-2015

Historic Short-term Investments for Biocryst Pharmaceuticals (BCRX) over the last 3 years, with Sep 2015 value amounting to $23.7 million.

  • Biocryst Pharmaceuticals' Short-term Investments rose 296.52% to $23.7 million in Q3 2015 from the same period last year, while for Sep 2015 it was $23.7 million, marking a year-over-year increase of 296.52%. This contributed to the annual value of $18.2 million for FY2014, which is 7.94% up from last year.
  • Per Biocryst Pharmaceuticals' latest filing, its Short-term Investments stood at $23.7 million for Q3 2015, which was up 34.78% from $17.6 million recorded in Q2 2015.
  • Biocryst Pharmaceuticals' 5-year Short-term Investments high stood at $40.6 million for Q2 2011, and its period low was $6.0 million during Q3 2014.
  • Over the past 3 years, Biocryst Pharmaceuticals' median Short-term Investments value was $17.6 million (recorded in 2015), while the average stood at $16.3 million.
  • Per our database at Business Quant, Biocryst Pharmaceuticals' Short-term Investments plummeted by 63.87% in 2014 and then spiked by 296.52% in 2015.
  • Quarterly analysis of 5 years shows Biocryst Pharmaceuticals' Short-term Investments stood at $25.3 million in 2011, then tumbled by 41.81% to $14.7 million in 2012, then grew by 14.84% to $16.9 million in 2013, then increased by 7.94% to $18.2 million in 2014, then soared by 296.52% to $23.7 million in 2015.
  • Its Short-term Investments stands at $23.7 million for Q3 2015, versus $17.6 million for Q2 2015 and $19.2 million for Q1 2015.